VIDEO: Photobiomodulation shows positive 24-month results in patients with dry AMD

WAILEA, Hawaii — In this Healio video perspective from Retina 2024, Marion R. Munk, MD, PhD, overviews data investigating multiwavelength photobiomodulation for the treatment of dry age-related macular degeneration.
The LIGHTSITE III study, which included 148 eyes treated with either the LumiThera Valeda light delivery system or sham, met its primary outcome of achieving statistically significant improvement in visual acuity among the multiwavelength photobiomodulation cohort compared with the sham arm.
Munk also reported a statistically significant reduction in the conversion to

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart